Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations
- PMID: 19433779
- PMCID: PMC4913772
- DOI: 10.1161/HYPERTENSIONAHA.109.129098
Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations
Abstract
We used data from the National Birth Defects Prevention Study, a population-based, case-control study, to examine whether previously reported associations between antihypertensive medications and cardiovascular malformations could be confirmed and to explore whether new associations might be identified. Cases (n=5021) were ascertained through birth defects surveillance systems from 1997 through 2003 in 10 US states. Controls (n=4796) were live births without birth defects selected randomly from birth certificates or hospital discharge listings in the same geographic regions. Logistic regression was used to examine the relationship between antihypertensive medication treatment and the occurrence of cardiovascular malformations while controlling for confounding variables. First-trimester treatment with antihypertensive medication was associated with pulmonary valve stenosis (odds ratio [OR]: 2.6; 95% CI: 1.3 to 5.4), Ebstein malformation (crude OR: 11.4; exact 95% CI: 2.8 to 34.1), coarctation of the aorta (OR: 3.0; 95% CI: 1.3 to 6.6), and secundum atrial septal defects (OR: 2.4; 95% CI: 1.3 to 4.4). Treatment initiated after the first trimester was associated with pulmonary valve stenosis (OR: 2.4; 95% CI: 1.1 to 5.4), perimembranous ventricular septal defects (OR: 2.3; 95% CI: 1.2 to 4.6), and secundum atrial septal defects (OR: 2.4; 95% CI: 1.3 to 4.4). Untreated hypertension was associated with Ebstein malformation (OR: 2.1; 95% CI: 1.0 to 4.3) and secundum atrial septal defects (OR: 1.3; 95% CI: 1.0 to 1.6). Antihypertensive medication use and/or the underlying hypertension might increase the risk of having an infant with specific left and right obstructive and septal defects. Additional studies with adequate power will be needed to confirm these findings.
Similar articles
-
Maternal hypertensive disorders, antihypertensive medication use, and the risk of birth defects: a case-control study.BJOG. 2015 Jun;122(7):1002-9. doi: 10.1111/1471-0528.13138. Epub 2014 Nov 14. BJOG. 2015. PMID: 25395267
-
Maternal Antihypertensive Medication Use and Congenital Heart Defects: Updated Results From the National Birth Defects Prevention Study.Hypertension. 2017 May;69(5):798-805. doi: 10.1161/HYPERTENSIONAHA.116.08773. Epub 2017 Apr 3. Hypertension. 2017. PMID: 28373593 Free PMC article.
-
Maternal antihypertensive medication use and selected birth defects in the National Birth Defects Prevention Study.Birth Defects Res. 2018 Nov 15;110(19):1433-1442. doi: 10.1002/bdr2.1372. Epub 2018 Sep 10. Birth Defects Res. 2018. PMID: 30260586 Free PMC article.
-
Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports.BMJ. 2015 Jul 8;351:h3190. doi: 10.1136/bmj.h3190. BMJ. 2015. PMID: 26156519 Free PMC article. Review.
-
The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.Br J Clin Pharmacol. 2016 Apr;81(4):589-604. doi: 10.1111/bcp.12849. Epub 2016 Jan 26. Br J Clin Pharmacol. 2016. PMID: 26613360 Free PMC article. Review.
Cited by
-
Use of Real-World Data and Machine Learning to Screen for Maternal and Paternal Characteristics Associated with Cardiac Malformations.Res Sq [Preprint]. 2024 Jun 11:rs.3.rs-4490534. doi: 10.21203/rs.3.rs-4490534/v1. Res Sq. 2024. PMID: 38947037 Free PMC article. Preprint.
-
Fever and antibiotic use in maternal urinary tract infections during pregnancy and risk of congenital heart defects: Findings from the National Birth Defects Prevention Study.Birth Defects Res. 2024 Jan;116(1):e2281. doi: 10.1002/bdr2.2281. Epub 2023 Dec 13. Birth Defects Res. 2024. PMID: 38093546
-
A Review on the Vagus Nerve and Autonomic Nervous System During Fetal Development: Searching for Critical Windows.Front Neurosci. 2021 Sep 20;15:721605. doi: 10.3389/fnins.2021.721605. eCollection 2021. Front Neurosci. 2021. PMID: 34616274 Free PMC article.
-
Environmental and Genetic Risk Factors of Congenital Anomalies: an Umbrella Review of Systematic Reviews and Meta-Analyses.J Korean Med Sci. 2021 Jul 19;36(28):e183. doi: 10.3346/jkms.2021.36.e183. J Korean Med Sci. 2021. PMID: 34282604 Free PMC article. Review.
-
Clinical outcomes of hypertensive disorders in pregnancy in the offspring during perinatal period, childhood, and adolescence.J Hum Hypertens. 2021 Dec;35(12):1063-1073. doi: 10.1038/s41371-021-00550-3. Epub 2021 May 13. J Hum Hypertens. 2021. PMID: 33986467 Review.
References
-
- Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183:S1–S22. - PubMed
-
- Afifi Y, Churchill D. Pharmacological treatment of hypertension in pregnancy. Curr Pharm Des. 2003;9:1745–1753. - PubMed
-
- Magee LA. Treating hypertension in women of child-bearing age and during pregnancy. Drug Saf. 2001;24:457–474. - PubMed
-
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr, Jones DW, Materson BJ, Oparil S, Wright JT, Jr, Roccella EJ. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–1252. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical